171 results on '"Wanda D. Barfield"'
Search Results
2. Equity in Policies Regarding Urine Drug Testing in Infants
- Author
-
Daria, Murosko, Kathryn, Paul, Wanda D, Barfield, Diana, Montoya-Williams, and Joanna, Parga-Belinkie
- Subjects
Policy ,Health Equity ,Pediatrics, Perinatology and Child Health ,Infant ,Humans - Published
- 2022
3. COVID-19 Vaccination and Intent Among Pregnant Women, United States, April 2021
- Author
-
Hilda Razzaghi, Katherine E. Kahn, Svetlana Masalovich, Carla L. Black, Kimberly H. Nguyen, Wanda D. Barfield, Romeo R. Galang, and James A. Singleton
- Subjects
COVID-19 Vaccines ,Influenza Vaccines ,Pregnancy ,Influenza, Human ,Vaccination ,Public Health, Environmental and Occupational Health ,COVID-19 ,Humans ,Female ,Pregnant Women ,Pregnancy Complications, Infectious ,United States - Abstract
Objectives: National data on COVID-19 vaccination coverage among pregnant women are limited. We assessed COVID-19 vaccination coverage and intent, factors associated with COVID-19 vaccination, reasons for nonvaccination, and knowledge, attitudes, and beliefs related to COVID-19 illness and vaccination among pregnant women in the United States. Methods: Data from an opt-in internet panel survey of pregnant women conducted March 31–April 16, 2021, assessed receipt of ≥1 dose of any COVID-19 vaccine during pregnancy. The sample included 1516 women pregnant any time during December 1, 2020–April 16, 2021, who were not fully vaccinated before pregnancy. We used multivariable logistic regression to determine variables independently associated with receipt of COVID-19 vaccine. Results: As of April 16, 2021, 21.7% of pregnant women had received ≥1 dose of COVID-19 vaccine during pregnancy, 24.0% intended to receive a vaccine, 17.2% were unsure, and 37.1% did not intend to receive a vaccine. Pregnant women with (vs without) a health care provider recommendation (adjusted prevalence ratio [aPR] = 4.86), those who lived (vs not) with someone with a condition that could increase risk for serious medical complications of COVID-19 (aPR = 2.11), and those who had received (vs not) an influenza vaccination (aPR = 2.35) were more likely to receive a COVID-19 vaccine. Common reasons for nonvaccination included concerns about safety risk to baby (37.2%) or self (34.6%) and about rapid vaccine development (29.7%) and approval (30.9%). Conclusions: Our findings indicate a continued need to emphasize the benefits of COVID-19 vaccination during pregnancy and to widely disseminate the recommendations of the Centers for Disease Control and Prevention and other clinical professional societies for all pregnant women to be vaccinated.
- Published
- 2022
4. Sudden Unexpected Infant Deaths: 2015–2020
- Author
-
Carrie K. Shapiro-Mendoza, Kate R. Woodworth, Carri R. Cottengim, Alexa B. Erck Lambert, Elizabeth M. Harvey, Michael Monsour, Sharyn E. Parks, and Wanda D. Barfield
- Subjects
Pediatrics, Perinatology and Child Health - Abstract
OBJECTIVE Although the US infant mortality rate reached a record low in 2020, the sudden infant death syndrome (SIDS) rate increased from 2019. To understand if the increase was related to changing death certification practices or the coronavirus disease 2019 (COVID-19) pandemic, we examined sudden unexpected infant death (SUID) rates as a group, by cause, and by race and ethnicity. METHODS We estimated SUID rates during 2015 to 2020 using US period-linked birth and death data. SUID included SIDS, unknown cause, and accidental suffocation and strangulation in bed. We examined changes in rates from 2019 to 2020 and assessed linear trends during prepandemic (2015–2019) using weighted least squares regression. We also assessed race and ethnicity trends and quantified COVID-19–related SUID. RESULTS Although the SIDS rate increased significantly from 2019 to 2020 (P < .001), the overall SUID rate did not (P = .24). The increased SIDS rate followed a declining linear trend in SIDS during 2015 to 2019 (P < .001). Other SUID causes did not change significantly. Our race and ethnicity analysis showed SUID rates increased significantly for non-Hispanic Black infants from 2019 to 2020, widening the disparities between these two groups during 2017 to 2019. In 2020, CONCLUSIONS Diagnositic shifting likely explained the increased SIDS rate in 2020. Why the SUID rate increased for non-Hispanic Black infants is unknown, but warrants continued monitoring. Interventions are needed to address persistent racial and ethnic disparities in SUID.
- Published
- 2023
5. Summary of neonatal and maternal transport and reimbursement policies—a 5-year update
- Author
-
Carla L. DeSisto, Ekwutosi M. Okoroh, Charlan D. Kroelinger, and Wanda D. Barfield
- Subjects
Pediatrics, Perinatology and Child Health ,Obstetrics and Gynecology - Published
- 2022
6. A Field Placement Approach to Enhance State and Local Capacity for Opioid-Related Issues Affecting Pregnant and Postpartum People and Infants Prenatally Exposed to Opioids and Other Substances
- Author
-
Mary Kate, Weber, Emmy L, Tran, Charlan D, Kroelinger, Celeste, Ellison, Trisha, Mueller, Lisa, Romero, Kecia L, Ellick, Marion E, Rice, Gabriela, Garcia, Ellen, Pliska, Sanaa, Akbarali, Ramya, Dronamraju, Katrin, Patterson, S Nicole, Fehrenbach, and Wanda D, Barfield
- Subjects
Postpartum Period ,Infant, Newborn ,Infant ,General Medicine ,Opioid-Related Disorders ,United States ,Article ,Analgesics, Opioid ,Pregnancy ,Humans ,Female ,Centers for Disease Control and Prevention, U.S ,Child ,Neonatal Abstinence Syndrome - Abstract
Opioid use disorder (OUD) poses a significant public health concern impacting maternal and infant outcomes. In 2018, the Centers for Disease Control and Prevention (CDC) partnered with the Association of State and Territorial Health Officials (ASTHO) to develop the Opioid use disorder, Maternal outcomes, and Neonatal abstinence syndrome Initiative Learning Community (OMNI LC) to identify and disseminate best practices and strategies for implementing systems-level changes in state health departments to address OUD affecting pregnant and postpartum persons and infants prenatally exposed to opioids. In 2019, the OMNI LC incorporated a field placement approach that assigned temporary field placement staff in five select OMNI LC states to provide important linkages, facilitate information sharing, and strengthen capacity among state and local health departments and other partners supporting maternal and child health communities affected by the opioid crisis. Using an implementation science framework, the field placement approach was assessed using five implementation outcome measures: appropriateness, acceptability, implementation cost, sustainability, and feasibility. Written responses from the participating OMNI LC states on these implementation outcome measures were analyzed to (1) highlight key strategies used by field placement staff, (2) assess the implementation of the OMNI LC field placement approach within the context of implementation science, and (3) identify implementation barriers. This report describes the implementation of a temporary field placement approach and suggests that this approach could be replicated to enhance state and local capacity to respond to the opioid crisis or other high-consequence events.
- Published
- 2022
7. Maternal and neonatal risk-appropriate care: gaps, strategies, and areas for further research
- Author
-
Carla L. DeSisto, Charlan D. Kroelinger, Madison Levecke, Sanaa Akbarali, Ellen Pliska, and Wanda D. Barfield
- Subjects
Pediatrics, Perinatology and Child Health ,Obstetrics and Gynecology - Published
- 2023
8. Emergency Preparedness and Response: Highlights from the Division of Reproductive Health, 2011–2021
- Author
-
Mirna, Perez, Romeo R, Galang, Margaret Christine, Snead, Penelope, Strid, Connie L, Bish, Van T, Tong, Wanda D, Barfield, Carrie K, Shapiro-Mendoza, Marianne E, Zotti, Sascha, Ellington, and Bailey, Wallace
- Subjects
Reproductive Health ,Pregnancy ,Communication ,Civil Defense ,Humans ,Disaster Planning ,Female ,Public Health ,General Medicine ,Centers for Disease Control and Prevention, U.S ,United States - Abstract
This report provides historical context and rationale for coordinated, systematic, and evidence-based public health emergency preparedness and response (EPR) activities to address the needs of women of reproductive age. Needs of pregnant and postpartum women, and infants-before, during, and after public health emergencies-are highlighted. Four focus areas and related activities are described: (1) public health science; (2) clinical guidance; (3) partnerships, communication, and outreach; and (4) workforce development. Finally, the report summarizes major activities of the Division of Reproductive Health's EPR Team at the Centers for Disease Control and Prevention.
- Published
- 2021
9. Connecting the Dots: Public Health, Clinical, and Community Connections to Improve Contraception Access
- Author
-
Ellen S, Pliska, Wanda D, Barfield, and Michael R, Fraser
- Subjects
Contraception ,Family Planning Services ,Public Health, Environmental and Occupational Health ,Humans ,Public Health ,Contraception Behavior ,Health Services Accessibility - Published
- 2022
10. The Michigan Plan for Appropriate Tailored Healthcare in Pregnancy Prenatal Care Recommendations
- Author
-
Mark A Turrentine, Alex F. Peahl, Wanda D. Barfield, Suni Jo Roberts, Steven J. Bernstein, Vineet Chopra, Allison R. Powell, Sean D Blackwell, and Christopher M. Zahn
- Subjects
Pregnancy ,medicine.medical_specialty ,Telemedicine ,business.industry ,MEDLINE ,Obstetrics and Gynecology ,Plan (drawing) ,Prenatal care ,medicine.disease ,Family medicine ,Health care ,medicine ,Social determinants of health ,business ,Risk assessment - Abstract
Objective To describe MiPATH (the Michigan Plan for Appropriate Tailored Healthcare) in pregnancy panel process and key recommendations for prenatal care delivery. Methods We conducted an appropriateness study using the RAND Corporation and University of California Los Angeles Appropriateness Method, a modified e-Delphi process, to develop MiPATH recommendations using sequential steps: 1) definition and scope of key terms, 2) literature review and data synthesis, 3) case scenario development, 4) panel selection and scenario revisions, and 5) two rounds of panel appropriateness ratings with deliberation. Recommendations were developed for average-risk pregnant individuals (eg, individuals not requiring care by maternal-fetal medicine specialists). Because prenatal services (eg, laboratory tests, vaccinations) have robust evidence, panelists considered only how services are delivered (eg, visit frequency, telemedicine). Results The appropriateness of key aspects of prenatal care delivery across individuals with and without common medical and pregnancy complications, as well as social and structural determinants of health, was determined by the panel. Panelists agreed that a risk assessment for medical, social, and structural determinants of health should be completed as soon as individuals present for care. Additionally, the panel provided recommendations for: 1) prenatal visit schedules (care initiation, visit timing and frequency, routine pregnancy assessments), 2) integration of telemedicine (virtual visits and home devices), and 3) care individualization. Panelists recognized significant gaps in existing evidence and the need for policy changes to support equitable care with changing practices. Conclusion The MiPATH recommendations offer more flexible prenatal care delivery for average-risk individuals.
- Published
- 2021
11. Impacts of the COVID-19 Pandemic on Nationwide Chronic Disease Prevention and Health Promotion Activities
- Author
-
Lilanthi Balasuriya, Peter A. Briss, Evelyn Twentyman, Jennifer L. Wiltz, Lisa C. Richardson, Elizabeth T. Bigman, Janet S. Wright, Ruth Petersen, Casey J. Hannan, Craig W. Thomas, Wanda D. Barfield, Deirdre L. Kittner, and Karen A. Hacker
- Subjects
Epidemiology ,Public Health, Environmental and Occupational Health - Published
- 2022
12. US county-level estimation for maternal and infant health-related behavior indicators using pregnancy risk assessment monitoring system data, 2016–2018
- Author
-
Yan Wang, Heather Tevendale, Hua Lu, Shanna Cox, Susan A. Carlson, Rui Li, Holly Shulman, Brian Morrow, Philip A. Hastings, and Wanda D. Barfield
- Subjects
Pregnancy ,Epidemiology ,Population Surveillance ,Health Behavior ,Public Health, Environmental and Occupational Health ,Humans ,Infant ,Family ,Female ,Child ,Risk Assessment - Abstract
Background There is a critical need for maternal and child health data at the local level (for example, county), yet most counties lack sustainable resources or capabilities to collect local-level data. In such case, model-based small area estimation (SAE) could be a feasible approach. SAE for maternal or infant health-related behaviors at small areas has never been conducted or evaluated. Methods We applied multilevel regression with post-stratification approach to produce county-level estimates using Pregnancy Risk Assessment Monitoring System (PRAMS) data, 2016–2018 (n = 65,803 from 23 states) for 2 key outcomes, breastfeeding at 8 weeks and infant non-supine sleeping position. Results Among the 1,471 counties, the median model estimate of breastfeeding at 8 weeks was 59.8% (ranged from 34.9 to 87.4%), and the median of infant non-supine sleeping position was 16.6% (ranged from 10.3 to 39.0%). Strong correlations were found between model estimates and direct estimates for both indicators at the state level. Model estimates for both indicators were close to direct estimates in magnitude for Philadelphia County, Pennsylvania. Conclusion Our findings support this approach being potentially applied to other maternal and infant health and behavioral indicators in PRAMS to facilitate public health decision-making at the local level.
- Published
- 2022
13. Assisted Reproductive Technology Surveillance — United States, 2017
- Author
-
Lee Warner, Saswati Sunderam, Dmitry M. Kissin, Sheree L. Boulet, Charlan D. Kroelinger, Yujia Zhang, Wanda D. Barfield, and Amy Jewett
- Subjects
Adult ,medicine.medical_specialty ,Health (social science) ,Adolescent ,Reproductive Techniques, Assisted ,Epidemiology ,Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,media_common.quotation_subject ,Population ,Fertility ,Young Adult ,Health Information Management ,Pregnancy ,medicine ,Humans ,education ,media_common ,Surveillance Summaries ,education.field_of_study ,Assisted reproductive technology ,business.industry ,Public health ,Infant, Newborn ,Pregnancy Outcome ,Infant, Low Birth Weight ,medicine.disease ,United States ,Fertility clinic ,Low birth weight ,Population Surveillance ,Premature Birth ,Female ,Multiple birth ,Pregnancy, Multiple ,medicine.symptom ,business ,Infant, Premature ,Demography - Abstract
Problem/Condition Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Although the majority of infants conceived through ART are singletons, women who undergo ART procedures are more likely than women who conceive naturally to have multiple-birth infants because multiple embryos may be transferred. Multiple births can pose substantial risks for both mothers and infants, including obstetric complications, preterm birth (37 years). This year, single-embryo transfer (SET) rates among all embryo-transfer procedures are presented instead of elective single-embryo transfer procedures previously reported. Nationally, SET rates were 67.3% (range: 38.9% in South Dakota to 90.4% in Delaware), 65.0% (range: 23.6% in Puerto Rico to 89.4% in Delaware), and 60.0% (range: 28.6% in Puerto Rico to 83.1% in Delaware) among women aged 37 years, respectively. In 2017, ART contributed to 1.9% of all infants born in the United States (range: 0.4% in Puerto Rico to 5.0% in Massachusetts). Approximately 73.6% of ART-conceived infants were singleton infants. Overall, ART contributed to 14.7% of all multiple births, including 14.7% of all twin infants and 17.3% of all triplets and higher-order infants. ART-conceived twins accounted for approximately 96.5% (18,890 of 19,570) of all ART-conceived infants born in multiple deliveries. The percentage of multiple births was higher among infants conceived with ART (26.4%) than among all infants born in the total birth population (3.4%). Approximately 25.5% of ART-conceived infants were twins, and 0.9% were triplets and higher-order infants. Nationally, infants conceived with ART contributed to 4.5% of all low birthweight (
- Published
- 2020
14. Preventing Vector-Borne Transmission of Zika Virus Infection During Pregnancy, Puerto Rico, USA, 2016–2017
- Author
-
Katherine, Kortsmit, Beatriz, Salvesen von Essen, Lee, Warner, Denise V, D'Angelo, Ruben A, Smith, Carrie K, Shapiro-Mendoza, Holly B, Shulman, Wanda Hernández, Virella, Aspy, Taraporewalla, Leslie, Harrison, Sascha, Ellington, Wanda D, Barfield, Denise J, Jamieson, Shanna, Cox, Karen, Pazol, Patricia, Garcia Díaz, Beatriz Rios, Herrera, and Manuel Vargas, Bernal
- Subjects
Adult ,prevention strategies ,lcsh:Medicine ,Mosquito Vectors ,Disease Outbreaks ,Zika virus ,lcsh:Infectious and parasitic diseases ,Young Adult ,Protective Clothing ,parasitic diseases ,prenatal counseling ,Humans ,viruses ,PRAMS-ZPER ,lcsh:RC109-216 ,Bites and Stings ,microcephaly ,Pregnancy Complications, Infectious ,insect repellent ,Preventing Vector-Borne Transmission of Zika Virus Infection during Pregnancy, Puerto Rico, USA, 2016–2017 ,Zika Virus Infection ,Puerto Rico ,fungi ,lcsh:R ,Dispatch ,United States ,Insect Repellents ,Zika prevalence ,Female ,pregnancy ,vector-borne transmission - Abstract
We examined pregnant women’s use of personal protective measures to prevent mosquito bites during the 2016–2017 Zika outbreak in Puerto Rico. Healthcare provider counseling on recommended measures was associated with increased use of insect repellent among pregnant women but not with wearing protective clothing.
- Published
- 2020
15. Hypertensive Disorders in Pregnancy and Mortality at Delivery Hospitalization - United States, 2017-2019
- Author
-
Nicole D. Ford, Shanna Cox, Jean Y. Ko, Lijing Ouyang, Lisa Romero, Tiffany Colarusso, Cynthia D. Ferre, Charlan D. Kroelinger, Donald K. Hayes, and Wanda D. Barfield
- Subjects
Hospitalization ,Pregnancy Complications ,Health (social science) ,Health Information Management ,Epidemiology ,Pregnancy ,Health, Toxicology and Mutagenesis ,Prevalence ,Humans ,Female ,General Medicine ,Hypertension, Pregnancy-Induced ,United States - Abstract
Hypertensive disorders in pregnancy (HDPs), defined as prepregnancy (chronic) or pregnancy-associated hypertension, are common pregnancy complications in the United States.* HDPs are strongly associated with severe maternal complications, such as heart attack and stroke (1), and are a leading cause of pregnancy-related death in the United States.
- Published
- 2022
16. Assisted Reproductive Technology Surveillance - United States, 2018
- Author
-
Saswati Sunderam, Dmitry M. Kissin, Yujia Zhang, Amy Jewett, Sheree L. Boulet, Lee Warner, Charlan D. Kroelinger, and Wanda D. Barfield
- Subjects
Adult ,Health (social science) ,Adolescent ,Reproductive Techniques, Assisted ,Epidemiology ,Health, Toxicology and Mutagenesis ,Infant, Newborn ,Pregnancy Outcome ,Infant ,United States ,Young Adult ,Health Information Management ,Pregnancy ,Population Surveillance ,Pregnancy, Twin ,Humans ,Premature Birth ,Female ,Infant, Premature - Abstract
Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Although the majority of infants conceived through ART are singletons, women who undergo ART procedures are more likely than women who conceive naturally to have multiple births because multiple embryos might be transferred. Multiple births can pose substantial risks for both mothers and infants, including obstetric complications, preterm birth (37 weeks), and low birthweight (2,500 g). This report provides state-specific information for the United States (including the District of Columbia and Puerto Rico) on ART procedures performed in 2018 and compares birth outcomes that occurred in 2018 (resulting from ART procedures performed in 2017 and 2018) with outcomes for all infants born in the United States in 2018.2018.In 1995, CDC began collecting data on ART procedures performed in fertility clinics in the United States as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (Public Law 102-493 [October 24, 1992]). Data are collected through the National ART Surveillance System (NASS), a web-based data collection system developed by CDC. This report includes data from the 50 U.S. states, the District of Columbia, and Puerto Rico.In 2018, a total of 203,119 ART procedures (range: 196 in Alaska to 26,028 in California) were performed in 456 U.S. fertility clinics and reported to CDC. These procedures resulted in 73,831 live-birth deliveries (range: 76 in Puerto Rico and Wyoming to 9,666 in California) and 81,478 infants born (range: 84 in Wyoming to 10,620 in California). Nationally, among women aged 15-44 years, the rate of ART procedures performed was 3,135 per 1 million women. ART use exceeded 1.5 times the national rate in seven states (Connecticut, Illinois, Maryland, Massachusetts, New Jersey, New York, and Rhode Island) and the District of Columbia. ART use rates exceeded the national rate in an additional seven states (California, Delaware, Hawaii, New Hampshire, Utah, Vermont, and Virginia). Nationally, among all ART transfer procedures, the average number of embryos transferred was similar across age groups (1.3 among women aged35 years, 1.3 among women aged 35-37 years, and 1.4 among women aged37 years). The national single-embryo transfer (SET) rate among all embryo-transfer procedures was 74.1% among women aged35 years (range: 28.2% in Puerto Rico to 89.5% in Delaware), 72.8% among women aged 35-37 years (range: 30.6% in Puerto Rico to 93.7% in Delaware), and 66.4% among women aged37 years (range: 27.1% in Puerto Rico to 85.3% in Delaware). In 2018, ART contributed to 2.0% of all infants born in the United States (range: 0.4% in Puerto Rico to 5.1% in Massachusetts) from procedures performed in 2017 and 2018. Approximately 78.6% of ART-conceived infants were singleton infants. Overall, ART contributed to 12.5% of all multiple births, including 12.5% of all twin births and 13.3% of all triplets and higher-order births. ART-conceived twins accounted for approximately 97.1% (15,532 of 16,001) of all ART-conceived multiple births. The percentage of multiple births was higher among infants conceived with ART (21.4%) than among all infants born in the total birth population (3.3%). Approximately 20.7% (15,532 of 74,926) of ART-conceived infants were twins, and 0.6% (469 of 74,926) were triplets and higher-order multiples. Nationally, infants conceived with ART contributed to 4.2% of all low birthweight (2,500 g) infants. Among ART-conceived infants, 18.3% were low birthweight compared with 8.3% among all infants. ART-conceived infants contributed to 5.1% of all preterm (gestational age37 weeks) infants. The percentage of preterm births was higher among infants conceived with ART (26.1%) than among all infants born in the total birth population (10.0%). The percentage of low birthweight among singletons was 8.3% among ART-conceived infants and 6.6% among all infants born. The percentage of preterm births among ART-conceived singleton infants was 14.9% compared with 8.3% among all singleton infants. The percentages of small for gestational age infants was 7.3% among ART-conceived infants compared with 9.4% among all infants.Although singleton infants accounted for the majority of ART-conceived infants, multiple births from ART varied substantially among states and nationally, contributing to12% of all twins, triplets, and higher-order multiple infants born in the United States. Because multiple births are associated with higher rates of prematurity than singleton births, the contribution of ART to poor birth outcomes continues to be noteworthy. Although SET rates increased among all age groups, variations in SET rates among states and territories remained, which might reflect variations in embryo-transfer practices among fertility clinics and might in part account for variations in multiple birth rates among states and territories.Reducing the number of embryos transferred and increasing use of SET, when clinically appropriate, can help reduce multiple births and related adverse health consequences for both mothers and infants. Whereas risks to mothers from multiple-birth pregnancy include higher rates of caesarean delivery, gestational hypertension, and gestational diabetes, infants from multiple births are at increased risk for numerous adverse sequelae such as preterm birth, birth defects, and developmental disabilities. Long-term follow-up of ART infants through integration of existing maternal and infant health surveillance systems and registries with data available from NASS might be useful for monitoring adverse outcomes on a population basis.
- Published
- 2022
17. Participation in survey research among mothers with a recent live birth: A comparison of mothers with living versus deceased infants - Findings from the Pregnancy Risk Assessment Monitoring System, 2016-2019
- Author
-
Katherine Kortsmit, Holly Shulman, Ruben A. Smith, Carrie K. Shapiro‐Mendoza, Sharyn E. Parks, Suzanne Folger, Maura Whiteman, Leslie Harrison, Shanna Cox, Lauren Christiansen‐Lindquist, Wanda D. Barfield, and Lee Warner
- Subjects
Epidemiology ,Pregnancy ,Population Surveillance ,Surveys and Questionnaires ,Pediatrics, Perinatology and Child Health ,Infant ,Humans ,Mothers ,Female ,Live Birth ,Risk Assessment ,United States - Abstract
Despite high infant mortality rates in the United States relative to other developed countries, little is known about survey participation among mothers of deceased infants.To assess differences in survey response, contact and cooperation rates for mothers of deceased versus. living infants at the time of survey mailing (approximately 2-6 months postpartum), overall and by select maternal and infant characteristics.We analysed 2016-2019 data for 50 sites from the Pregnancy Risk Assessment Monitoring System (PRAMS), a site-specific, population-based surveillance system of mothers with a recent live birth. We assessed differences in survey participation between mothers of deceased and living infants. Using American Association for Public Opinion Research (AAPOR) standard definitions and terminology, we calculated proportions of mothers who participated and were successfully contacted among sampled mothers (weighted response and contact rates, respectively), and who participated among contacted mothers (weighted cooperation rate). We then constructed multivariable survey-weighted logistic regression models to examine the adjusted association between infant vital status and weighted response, contact and cooperation rates, within strata of maternal and infant characteristics.Among sampled mothers, 0.3% (weighted percentage, n = 2795) of infants had records indicating they were deceased at the time of survey mailing and 99.7% (weighted percentage, n = 344,379) did not. Mothers of deceased infants had lower unadjusted weighted response (48.3% vs. 56.2%), contact (67.9% vs. 74.3%) and cooperation rates (71.1% vs. 75.6%). However, after adjusting for covariates, differences in survey participation by infant vital status were reduced.After covariate adjustment, differences in PRAMS participation rates were attenuated. However, participation rates among mothers of deceased infants remain two to four percentage points lower compared with mothers of living infants. Strategies to increase PRAMS participation could inform knowledge about experiences and behaviours before, during and shortly after pregnancy to help reduce infant mortality.
- Published
- 2022
18. Association of smoke‐free laws with preterm or low birth weight deliveries—A multistate analysis
- Author
-
Wanda D. Barfield, Xu Ji, Shanna Cox, Rui Li, Brian S. Armour, Elizabeth A. Courtney-Long, and Scott D. Grosse
- Subjects
Data source ,business.industry ,030503 health policy & services ,Health Policy ,Ethnic group ,Differential effects ,03 medical and health sciences ,Low birth weight ,Smoke free laws ,0302 clinical medicine ,medicine ,Extraction methods ,030212 general & internal medicine ,medicine.symptom ,0305 other medical science ,Association (psychology) ,Healthcare Cost and Utilization Project ,business ,Demography - Abstract
OBJECTIVE To assess the association between the change in statewide smoke-free laws and the rate of preterm or low birth weight delivery hospitalizations. DATA SOURCE 2002-2013 Healthcare Cost and Utilization Project State Inpatient Databases. STUDY DESIGN Quasi-experimental difference-in-differences design. We used multivariate logistic models to estimate the association between the change in state smoke-free laws and preterm or low birth weight delivery hospitalizations. The analyses were also stratified by maternal race/ethnicity to examine the differential effects by racial/ethnic groups. DATA COLLECTION/EXTRACTION METHODS Delivery hospitalizations among women aged 15-49 years were extracted using the International Classification of Diseases, Ninth Revision, and Diagnosis-Related Group codes. PRINCIPAL FINDINGS Non-Hispanic black mothers had a higher rate of preterm or low birth weight delivery hospitalization than other racial/ethnic groups. Overall, there was no association between the change in smoke-free laws and preterm or low birth weight delivery rate. Among non-Hispanic black mothers, the change in statewide smoke-free laws was associated with a 0.9-1.9 percentage point (P
- Published
- 2020
19. Vital Signs: Prescription Opioid Pain Reliever Use During Pregnancy — 34 U.S. Jurisdictions, 2019
- Author
-
Jean Y. Ko, Heather D Tevendale, Lee Warner, Andrea E Strahan, Denise V. D’Angelo, Sarah C. Haight, Wanda D. Barfield, Beatriz Salvesen von Essen, Shanna Cox, Leslie J.S. Harrison, Charlan D. Kroelinger, and Brian Morrow
- Subjects
Adult ,medicine.medical_specialty ,Prescription Drugs ,Health (social science) ,Adolescent ,Prescription Drug Misuse ,Epidemiology ,Health, Toxicology and Mutagenesis ,Vital signs ,Risk Assessment ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Patient Education as Topic ,Health Information Management ,Pregnancy ,030225 pediatrics ,medicine ,Humans ,Full Report ,030212 general & internal medicine ,Medical prescription ,business.industry ,Public health ,Chronic pain ,Opioid use disorder ,General Medicine ,medicine.disease ,United States ,Analgesics, Opioid ,Opioid ,Health Care Surveys ,Prenatal Exposure Delayed Effects ,Family medicine ,Female ,Self Report ,Chronic Pain ,business ,medicine.drug - Abstract
Background Prescription opioid use during pregnancy has been associated with poor outcomes for mothers and infants. Studies using administrative data have estimated that 14%-22% of women filled a prescription for opioids during pregnancy; however, data on self-reported prescription opioid use during pregnancy are limited. Methods CDC analyzed 2019 data from the Pregnancy Risk Assessment Monitoring System (PRAMS) survey in 32 jurisdictions and maternal and infant health surveys in two additional jurisdictions not participating in PRAMS to estimate self-reported prescription opioid pain reliever (prescription opioid) use during pregnancy overall and by maternal characteristics among women with a recent live birth. This study describes source of prescription opioids, reasons for use, want or need to cut down or stop use, and receipt of health care provider counseling on how use during pregnancy can affect an infant. Results An estimated 6.6% of respondents reported prescription opioid use during pregnancy. Among these women, 21.2% reported misuse (a source other than a health care provider or a reason for use other than pain), 27.1% indicated wanting or needing to cut down or stop using, and 68.1% received counseling from a provider on how prescription opioid use during pregnancy could affect an infant. Conclusions and implications for public health practice Among respondents reporting opioid use during pregnancy, most indicated receiving prescription opioids from a health care provider and using for pain reasons; however, answers from one in five women indicated misuse. Improved screening for opioid misuse and treatment of opioid use disorder in pregnant patients might prevent adverse outcomes. Implementation of public health strategies (e.g., improving state prescription drug monitoring program use and enhancing provider training) can support delivery of evidence-based care for pregnant women.
- Published
- 2020
20. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM — 15 Hospitals, Massachusetts, 2017
- Author
-
Kelsey C. Coy, Wanda D. Barfield, Munish Gupta, Carrie K. Shapiro-Mendoza, Susan E. Manning, Charles Alpren, Kendra B. McDow, Jennifer Sinatra, Jean Y. Ko, Katherine C. Saunders, Sonal Goyal, Lisa Romero, Hafsatou Diop, Amelia A. Keaton, Katherine T. Fillo, Katarina Jones, and Chiara S. Moore
- Subjects
Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Health (social science) ,Epidemiology ,Substance-Related Disorders ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,Sensitivity and Specificity ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Health Information Management ,International Classification of Diseases ,Pregnancy ,030225 pediatrics ,medicine ,Humans ,030212 general & internal medicine ,Full Report ,Young adult ,media_common ,Controlled substance ,business.industry ,Public health ,Addiction ,Infant, Newborn ,ICD-10 ,Opioid use disorder ,General Medicine ,medicine.disease ,Hospitals ,Massachusetts ,Prenatal Exposure Delayed Effects ,Female ,Diagnosis code ,business ,Neonatal Abstinence Syndrome - Abstract
Opioid use disorder and neonatal abstinence syndrome (NAS) increased in Massachusetts from 1999 to 2013 (1,2). In response, in 2016, the state passed a law requiring birth hospitals to report the number of newborns who were exposed to controlled substances to the Massachusetts Department of Public Health (MDPH)* by mandating monthly reporting of International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnostic codes related to maternal dependence on opioids (F11.20) or benzodiazepines (F13.20) and to newborns affected by maternal use of drugs of addiction (P04.49) or experiencing withdrawal symptoms from maternal drugs of addiction (P96.1) separately.† MDPH uses these same codes for monthly, real-time crude estimates of NAS and uses P96.1 alone for official NAS state reporting.§ MDPH requested CDC's assistance in evaluating the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of either maternal or newborn codes to identify substance-exposed newborns, and of newborn exposure codes (both exposure [P04.49] or withdrawal [P96.1]) and the newborn code for withdrawal alone (P96.1) to identify infants with NAS cases related to three exposure scenarios: 1) opioids, 2) opioids or benzodiazepines, and 3) any controlled substance. Confirmed diagnoses of substance exposure and NAS abstracted from linked clinical records for 1,123 infants born in 2017 and their birth mothers were considered the diagnostic standard and were compared against hospital-reported ICD-10-CM codes. For identifying substance-exposed newborns across the three exposure scenarios, the newborn exposure codes had higher sensitivity (range = 31%-61%) than did maternal drug dependence codes (range = 16%-41%), but both sets of codes had high PPV (≥74%). For identifying NAS, for all exposure scenarios, the sensitivity for either newborn code (P04.49 or P96.1) was ≥92% and the PPV was ≥64%; for P96.1 alone the sensitivity was ≥79% and the PPV was ≥92% for all scenarios. Whereas ICD-10-CM codes are effective for NAS surveillance in Massachusetts, they should be applied cautiously for substance-exposed newborn surveillance. Surveillance for substance-exposed newborns using ICD-10-CM codes might be improved by increasing the use of validated substance-use screening tools and standardized facility protocols and improving communication between patients and maternal health and infant health care providers.
- Published
- 2020
21. Severe Coronavirus Infections in Pregnancy
- Author
-
Kate R. Woodworth, Romeo R. Galang, Penelope Strid, Mirna Perez, Margaret C. Snead, Carrie K. Shapiro-Mendoza, Karen Chang, Wanda D. Barfield, Sascha R. Ellington, Denise J. Jamieson, Dana Meaney-Delman, and Lawrence Duane House
- Subjects
medicine.medical_specialty ,Pediatrics ,Middle East respiratory syndrome coronavirus ,viruses ,Pneumonia, Viral ,Population ,Abortion ,medicine.disease_cause ,Asymptomatic ,Article ,Betacoronavirus ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,medicine ,Humans ,030212 general & internal medicine ,Pregnancy Complications, Infectious ,education ,Pandemics ,education.field_of_study ,030219 obstetrics & reproductive medicine ,SARS-CoV-2 ,business.industry ,Transmission (medicine) ,Public health ,Infant, Newborn ,Pregnancy Outcome ,COVID-19 ,virus diseases ,Obstetrics and Gynecology ,medicine.disease ,Infectious Disease Transmission, Vertical ,respiratory tract diseases ,Abortion, Spontaneous ,Systematic review ,Premature Birth ,Female ,medicine.symptom ,Coronavirus Infections ,business - Abstract
Objective To inform the current coronavirus disease 2019 (COVID-19) outbreak, we conducted a systematic literature review of case reports of Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, during pregnancy and summarized clinical presentation, course of illness, and pregnancy and neonatal outcomes. Data sources We searched MEDLINE and ClinicalTrials.gov from inception to April 23, 2020. Methods of study selection We included articles reporting case-level data on MERS-CoV, SARS-CoV, and SARS-CoV-2 infection in pregnant women. Course of illness, indicators of severe illness, maternal health outcomes, and pregnancy outcomes were abstracted from included articles. Tabulation, integration, and results We identified 1,328 unique articles, and 1,253 articles were excluded by title and abstract review. We completed full-text review on 75, and 29 articles were excluded by full-text review. Among 46 publications reporting case-level data, eight described 12 cases of MERS-CoV infection, seven described 17 cases of SARS-CoV infection, and 31 described 98 cases of SARS-CoV-2 infection. Clinical presentation and course of illness ranged from asymptomatic to severe fatal disease, similar to the general population of patients. Severe morbidity and mortality among women with MERS-CoV, SARS-CoV, or SARS-CoV-2 infection in pregnancy and adverse pregnancy outcomes, including pregnancy loss, preterm delivery, and laboratory evidence of vertical transmission, were reported. Conclusion Understanding whether pregnant women may be at risk for adverse maternal and neonatal outcomes from severe coronavirus infections is imperative. Data from case reports of SARS-CoV, MERS-CoV, and SAR-CoV-2 infections during pregnancy are limited, but they may guide early public health actions and clinical decision-making for COVID-19 until more rigorous and systematically collected data are available. The capture of critical data is needed to better define how this infection affects pregnant women and neonates. This review was not registered with PROSPERO.
- Published
- 2020
22. Preventing Sexual Transmission of Zika Virus Infection during Pregnancy, Puerto Rico, USA, 20161
- Author
-
Wanda D. Barfield, Aspy J. Taraporewalla, Denise J. Jamieson, Denise V. D’Angelo, Beatriz Salvesen von Essen, Ruben A. Smith, Sascha R. Ellington, Patricia Garcia Díaz, Shanna Cox, Lee Warner, Karen Pazol, Beatriz Rios Herrera, Carrie K. Shapiro-Mendoza, Manuel I. Vargas Bernal, Holly B. Shulman, Katie Kortsmit, Wanda Hernández Virella, and Leslie J.S. Harrison
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Pregnancy ,Sexual transmission ,biology ,Epidemiology ,business.industry ,virus diseases ,Outbreak ,medicine.disease ,biology.organism_classification ,law.invention ,Zika virus ,Infectious Diseases ,Condom ,law ,Family medicine ,medicine ,Consistent condom ,business ,Healthcare providers ,ZIKA PREVENTION - Abstract
We examined condom use throughout pregnancy during the Zika outbreak in Puerto Rico during 2016. Overall
- Published
- 2019
23. Workplace Leave and Breastfeeding Duration Among Postpartum Women, 2016-2018
- Author
-
Craig F. Garfield, Wanda D Barfield, Rui Li, Lee Warner, Cria G Perrine, Holly B Shulman, Shanna Cox, Carrie K. Shapiro-Mendoza, Katherine Kortsmit, and Denise V D'Angelo
- Subjects
Adult ,business.industry ,Postpartum Period ,Public Health, Environmental and Occupational Health ,Breastfeeding ,MEDLINE ,United States ,Article ,Parental Leave ,Breast Feeding ,Pregnancy ,Population Surveillance ,Medicine ,Humans ,Female ,Duration (project management) ,business ,Demography ,Women, Working - Abstract
Objectives. To examine associations of workplace leave length with breastfeeding initiation and continuation at 1, 2, and 3 months. Methods. We analyzed 2016 to 2018 data for 10 sites in the United States from the Pregnancy Risk Assessment Monitoring System, a site-specific, population-based surveillance system that samples women with a recent live birth 2 to 6 months after birth. Using multivariable logistic regression, we examined associations of leave length ( Results. Among 12 301 postpartum women who planned to or had returned to the job they had during pregnancy, 42.1% reported taking unpaid leave, 37.5% reported paid leave, 18.2% reported both unpaid and paid leave, and 2.2% reported no leave. Approximately two thirds (66.2%) of women reported taking less than 3 months of leave. Although 91.2% of women initiated breastfeeding, 81.2%, 72.1%, and 65.3% of women continued breastfeeding at 1, 2, and 3 months, respectively. Shorter leave length ( Conclusions. Women with less than 3 months of leave reported shorter breastfeeding duration than did women with 3 or more months of leave. (Am J Public Health. 2021;111(11):2036–2045. https://doi.org/10.2105/AJPH.2021.306484 )
- Published
- 2021
24. Summary of neonatal and maternal transport and reimbursement policies-a 5-year update
- Author
-
Carla L, DeSisto, Ekwutosi M, Okoroh, Charlan D, Kroelinger, and Wanda D, Barfield
- Subjects
Policy ,Transportation of Patients ,Insurance, Health, Reimbursement ,Infant, Newborn ,Humans ,Mothers ,Female ,United States - Abstract
To examine the number of states with neonatal and maternal transport and reimbursement policies in 2019, compared with 2014.We conducted a systematic review of web-based, publicly available information on neonatal and maternal transport policies for each state in 2019. Information was abstracted from rules, codes, licensure regulations, and planning and program documents, then summarized within two categories: transport and reimbursement policies.In 2019, 42 states had a policy for neonatal transport and 37 states had a policy for maternal transport, increasing by 8 and 7 states respectively. Further, 31 states had a reimbursement policy for neonatal transport and 11 states for maternal transport, increases of 1 state per category. Overall, the number of states with policies increased from 2014 to 2019.The number of state neonatal and maternal transport policies increased; these policies may support provision of care at the most risk-appropriate facilities.
- Published
- 2021
25. Assisted Reproductive Technology and Perinatal Mortality: Selected States (2006–2011)
- Author
-
Dmitry M. Kissin, Wanda D. Barfield, Sheree L. Boulet, Russell S. Kirby, Jeani Chang, Yujia Zhang, Dana Bernson, Glenn Copeland, and Sara Crawford
- Subjects
Infertility ,Assisted reproductive technology ,business.industry ,Perinatal mortality ,medicine.medical_treatment ,MEDLINE ,Obstetrics and Gynecology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,Health care ,Gestation ,Medicine ,030212 general & internal medicine ,business ,Perinatal Deaths ,Demography ,Cohort study - Abstract
This study aimed to compare trends and characteristics of assisted reproductive technology (ART) and non-ART perinatal deaths and to evaluate the association of perinatal mortality and method of conception (ART vs. non-ART) among ART and non-ART deliveries in Florida, Massachusetts, and Michigan from 2006 to 2011. Retrospective cohort study using linked ART surveillance and vital records data from Florida, Massachusetts, and Michigan. During 2006 to 2011, a total of 570 ART-conceived perinatal deaths and 25,158 non-ART conceived perinatal deaths were identified from the participating states. Overall, ART perinatal mortality rates were lower than non-ART perinatal mortality rates for both singletons (7.0/1,000 births vs. 10.2/1,000 births) and multiples (22.8/1,000 births vs. 41.2/1,000 births). At28 weeks of gestation, the risk of perinatal death among ART singletons was significantly lower than non-ART singletons (adjusted risk ratio [aRR] = 0.46, 95% confidence interval [CI]: 0.26-0.85). Similar results were observed among multiples at28 weeks of gestation (aRR = 0.64, 95% CI: 0.45-0.89). Our findings suggest that ART use is associated with a decreased risk of perinatal deaths prior to 28 weeks of gestation, which may be explained by earlier detection and management of fetal and maternal conditions among ART-conceived pregnancies. These findings provide valuable information for health care providers, including infertility specialists, obstetricians, and pediatricians when counseling ART users on risk of treatment.· ART use is associated with a decreased risk of perinatal deaths prior to 28 weeks of gestation.. · ART perinatal mortality rates were lower than that for non-ART perinatal mortality.. · This study used linked data to examine associations between use of ART and perinatal deaths..
- Published
- 2021
26. Seven years later: state neonatal risk-appropriate care policy consistency with the 2012 American Academy of Pediatrics Policy
- Author
-
Charlan D. Kroelinger, Wanda D. Barfield, Marion E. Rice, Ekwutosi M. Okoroh, and Carla L. DeSisto
- Subjects
medicine.medical_specialty ,business.industry ,Birth weight ,media_common.quotation_subject ,Staffing ,MEDLINE ,Specialty ,Infant, Newborn ,Obstetrics and Gynecology ,Gestational age ,Infant ,Pediatrics ,Article ,United States ,Consistency (negotiation) ,Policy ,State (polity) ,Family medicine ,Pediatrics, Perinatology and Child Health ,Medicine ,Humans ,Level of care ,business ,Child ,media_common - Abstract
OBJECTIVE: To assess consistency of state neonatal risk-appropriate care policies with the 2012 AAP policy seven years post-publication. STUDY DESIGN: Systematic, web-based review of all publicly available 2019 state neonatal levels of care policies. Information on infant risk (gestational age, birth weight), technology and equipment capabilities, and availability of specialty staffing used to define neonatal levels of care was extracted for review. RESULT: Half of states (50%) had a neonatal risk-appropriate care policy. Of those states, 88% had language consistent with AAP-defined Level I criteria, 80% with Level II, 56% with Level III, and 55% with Level IV. Comparing policies (2014–2019), consistency increased in state policies among all levels of care with the greatest increase among level IV criteria. CONCLUSION: States improved consistency of policy language by each level of care, though half of states still lack policy to provide minimum standards of care to the most vulnerable infants.
- Published
- 2021
27. Changes and geographic variation in rates of preterm birth and stillbirth during the prepandemic period and COVID-19 pandemic, according to health insurance claims in the United States, April-June 2019 and April-June 2020
- Author
-
Wanda D. Barfield, Lijing Ouyang, Shanna Cox, Cynthia Ferre, Yousra Mohamoud, and Jiajia Chen
- Subjects
2019-20 coronavirus outbreak ,Insurance, Health ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,Infant, Newborn ,COVID-19 ,Geographic variation ,General Medicine ,Stillbirth ,United States ,Geography ,Pregnancy ,Environmental health ,Pandemic ,Research Letter ,Health insurance ,Humans ,Premature Birth ,Female ,Pandemics - Published
- 2021
28. Designation of neonatal levels of care: a review of state regulatory and monitoring policies
- Author
-
Charlan D. Kroelinger, Ekwutosi M. Okoroh, Sarah M. Lasswell, Wanda D. Barfield, and David A. Goodman
- Subjects
Licensure ,business.industry ,media_common.quotation_subject ,MEDLINE ,Obstetrics and Gynecology ,medicine.disease ,Infant newborn ,Statute ,03 medical and health sciences ,0302 clinical medicine ,State agency ,Government regulation ,State (polity) ,030225 pediatrics ,Pediatrics, Perinatology and Child Health ,medicine ,030212 general & internal medicine ,Medical emergency ,business ,Health policy ,media_common - Abstract
Summarize policies on levels of neonatal care designation among 50 states and District of Columbia (DC). Systematic review of publicly available, web-based information on levels of neonatal care designation policies for each state/DC. Information on designating authorities, designation oversight, licensure requirement, and ongoing monitoring for designated levels of care abstracted from 2019 published rules, statutes, and regulations. Thirty-one (61%) of 50 states/DC had designated authority policies for neonatal levels of care. Fourteen (27%) incorporated oversight of neonatal levels of care into the licensure process. Among jurisdictions with designated authority, 25 (81%) used a state agency and 15 (48%) had direct oversight. Twenty-two (71%) of 31 states with a designating authority required ongoing monitoring, 14 (64%) used both hospital reporting and site visits for monitoring with only ten requiring site visits. Limited direct oversight influences regulation of regionalized systems, potentially impacting facility service monitoring and consequent management of vulnerable infants.
- Published
- 2019
29. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome
- Author
-
Wanda D. Barfield, Donna Addison, Charlan D. Kroelinger, Shanna Cox, Lisa Romero, Mary Kate Weber, Trish Mueller, Marion E. Rice, Carrie K. Shapiro-Mendoza, S. Nicole Fehrenbach, Jean Y. Ko, Margaret A. Honein, and Hadley R. Hickner
- Subjects
medicine.medical_specialty ,Health (social science) ,Epidemiology ,Health, Toxicology and Mutagenesis ,Poison control ,Suicide prevention ,Occupational safety and health ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Pregnancy ,030225 pediatrics ,Injury prevention ,Humans ,Medicine ,Full Report ,030212 general & internal medicine ,Psychiatry ,business.industry ,Postpartum Period ,Infant, Newborn ,Infant ,Capacity building ,Human factors and ergonomics ,Opioid use disorder ,General Medicine ,Opioid-Related Disorders ,medicine.disease ,United States ,Pregnancy Complications ,Prenatal Exposure Delayed Effects ,Female ,business ,Neonatal Abstinence Syndrome ,Postpartum period - Abstract
Since 1999, the rate of opioid use disorder (OUD) has more than quadrupled, from 1.5 per 1,000 delivery hospitalizations to 6.5 (1), with similar increases in incidence of neonatal abstinence syndrome (NAS) observed for infants (from 2.8 per 1,000 live births to 14.4) among Medicaid-insured deliveries (2). CDC's response to the opioid crisis involves strategies to prevent opioid overdoses and related harms by building state capacity and supporting providers, health systems, and payers.* Recognizing systems gaps in provision of perinatal care and services, CDC partnered with the Association of State and Territorial Health Officials (ASTHO) to launch the Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community (OMNI LC). OMNI LC supports systems change and capacity building in 12 states.† Qualitative data from participating states were analyzed to identify strategies, barriers, and facilitators for capacity building in state-defined focus areas. Most states focused on strategies to expand access to and coordination of quality services (10 of 12) or increase provider awareness and training (nine of 12). Fewer states focused on data, monitoring, and evaluation (four of 12); financing and coverage (three of 12); or ethical, legal, and social considerations (two of 12). By building capacity to strengthen health systems, state-identified strategies across all focus areas might improve the health trajectory of mothers, infants, and families affected by the U.S. opioid crisis.
- Published
- 2019
30. Racial/Ethnic Disparities in Pregnancy-Related Deaths — United States, 2007–2016
- Author
-
Shanna Cox, Nicole L. Davis, Wanda D. Barfield, Kristi Seed, Emily E. Petersen, Carrie K. Shapiro-Mendoza, David Goodman, Carla Syverson, and William M. Callaghan
- Subjects
Adult ,Proportionate mortality ,Health (social science) ,Epidemiology ,Health, Toxicology and Mutagenesis ,Ethnic group ,Quality care ,01 natural sciences ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Age groups ,Health facility ,Pregnancy ,Risk Factors ,Ethnicity ,Humans ,Medicine ,Full Report ,030212 general & internal medicine ,0101 mathematics ,Young adult ,business.industry ,Racial Groups ,010102 general mathematics ,Health Status Disparities ,General Medicine ,medicine.disease ,United States ,Racial ethnic ,Pregnancy Complications ,Female ,business ,Demography - Abstract
Approximately 700 women die in the United States each year as a result of pregnancy or its complications, and significant racial/ethnic disparities in pregnancy-related mortality exist (1). Data from CDC's Pregnancy Mortality Surveillance System (PMSS) for 2007-2016 were analyzed. Pregnancy-related mortality ratios (PRMRs) (i.e., pregnancy-related deaths per 100,000 live births) were analyzed by demographic characteristics and state PRMR tertiles (i.e., states with lowest, middle, and highest PRMR); cause-specific proportionate mortality by race/ethnicity also was calculated. Over the period analyzed, the U.S. overall PRMR was 16.7 pregnancy-related deaths per 100,000 births. Non-Hispanic black (black) and non-Hispanic American Indian/Alaska Native (AI/AN) women experienced higher PRMRs (40.8 and 29.7, respectively) than did all other racial/ethnic groups. This disparity persisted over time and across age groups. The PRMR for black and AI/AN women aged ≥30 years was approximately four to five times that for their white counterparts. PRMRs for black and AI/AN women with at least some college education were higher than those for all other racial/ethnic groups with less than a high school diploma. Among state PRMR tertiles, the PRMRs for black and AI/AN women were 2.8-3.3 and 1.7-3.3 times as high, respectively, as those for non-Hispanic white (white) women. Significant differences in cause-specific proportionate mortality were observed among racial/ethnic populations. Strategies to address racial/ethnic disparities in pregnancy-related deaths, including improving women's health and access to quality care in the preconception, pregnancy, and postpartum periods, can be implemented through coordination at the community, health facility, patient, provider, and system levels.
- Published
- 2019
31. Assisted Reproductive Technology Surveillance — United States, 2016
- Author
-
Lee Warner, Wanda D. Barfield, Saswati Sunderam, Yujia Zhang, William M. Callaghan, Dmitry M. Kissin, Sheree L. Boulet, and Suzanne G. Folger
- Subjects
Adult ,medicine.medical_specialty ,Health (social science) ,Adolescent ,Reproductive Techniques, Assisted ,Epidemiology ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,medicine.medical_treatment ,MEDLINE ,Fertility ,Young Adult ,Health Information Management ,Pregnancy ,medicine ,Humans ,Young adult ,media_common ,Surveillance Summaries ,Assisted reproductive technology ,business.industry ,Public health ,Infant, Newborn ,Pregnancy Outcome ,Infant, Low Birth Weight ,medicine.disease ,Fertility clinic ,United States ,Low birth weight ,Population Surveillance ,Premature Birth ,Female ,medicine.symptom ,Pregnancy, Multiple ,business ,Infant, Premature ,Demography - Abstract
Problem/Condition Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Although the majority of infants conceived through ART are singletons, women who undergo ART procedures are more likely than women who conceive naturally to deliver multiple-birth infants. Multiple births pose substantial risks for both mothers and infants, including obstetric complications, preterm delivery (37 years). Among women aged 1.5 times the national average. Although other factors might influence ART use, insurance coverage for infertility treatments accounts for some of the difference in per capita ART use observed among states because most states do not mandate any coverage for ART treatment. Public Health Action Twins account for almost all of ART-conceived multiple births born in multiple deliveries. Reducing the number of embryos transferred and increasing use of eSET, when clinically appropriate, could help reduce multiple births and related adverse health consequences for both mothers and infants. Because multiple-birth infants are at increased risk for numerous adverse sequelae that cannot be ascertained from the data collected through NASS alone, long-term follow-up of ART infants through integration of existing maternal and infant health surveillance systems and registries with data available from NASS might be useful for monitoring adverse outcomes.
- Published
- 2019
32. Social disadvantage and its effect on maternal and newborn health
- Author
-
Wanda D. Barfield
- Subjects
media_common.quotation_subject ,Mothers ,Racism ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,Environmental health ,Medicine ,Humans ,Infant Health ,Social determinants of health ,Socioeconomic status ,Poverty ,Minority Groups ,media_common ,030219 obstetrics & reproductive medicine ,business.industry ,Infant, Newborn ,Obstetrics and Gynecology ,Health equity ,Educational attainment ,United States ,Pediatrics, Perinatology and Child Health ,Unemployment ,Life course approach ,Educational Status ,Female ,business - Abstract
Social disadvantage impacts the health of women and newborns throughout the life course. Contributing factors such as low educational attainment, unemployment, poverty, and lack of health insurance disproportionately affects minority women of reproductive age in the United States. This article reviews social disadvantage as it contributes to health status and health disparities for mothers and newborns in the United States and highlights the opportunities to improve social and structural determinants of health to address these gaps.
- Published
- 2021
33. Assessment of Incidence and Factors Associated With Severe Maternal Morbidity After Delivery Discharge Among Women in the US
- Author
-
Shanna Cox, Jiajia Chen, Cynthia Ferre, Elena V. Kuklina, Wanda D. Barfield, and Rui Li
- Subjects
medicine.medical_specialty ,education.field_of_study ,Obstetrics ,business.industry ,Incidence (epidemiology) ,Research ,Population ,Obstetrics and Gynecology ,Retrospective cohort study ,General Medicine ,Odds ratio ,macromolecular substances ,Online Only ,Cohort ,Severity of illness ,medicine ,education ,business ,Medicaid ,Cohort study ,Original Investigation - Abstract
Key Points Question What proportion of de novo severe maternal morbidity is diagnosed after delivery discharge, and what are the most common factors and maternal characteristics associated with severe maternal morbidity among women in the US? Findings In this cohort study of 2 667 325 women in the US with delivery hospitalizations between 2010 and 2014, 14% and 16% of severe maternal morbidity among those with commercial and Medicaid insurance, respectively, developed de novo within 6 weeks after delivery discharge. The most common factors and maternal characteristics associated with severe maternal morbidity after delivery were different than those identified at delivery. Meaning The study’s findings suggest that expanding the focus of severe maternal morbidity assessment to the postdelivery discharge period could improve understanding of severe maternal morbidity and may create opportunities to improve maternity care., Importance Previous efforts to examine severe maternal morbidity (SMM) in the US have focused on delivery hospitalizations. Little is known about de novo SMM that occurs after delivery discharge. Objective To investigate the incidence, timing, factors, and maternal characteristics associated with de novo SMM after delivery discharge among women in the US. Design, Setting, and Participants In this retrospective cohort study, data from the IBM MarketScan Multi-State Medicaid database and the IBM MarketScan Commercial Claims and Encounters database were used to construct a sample of women aged 15 to 44 years who delivered between January 1, 2010, and September 30, 2014. Severe maternal morbidity was reported by the timing of diagnosis, and the associated maternal characteristics were examined. Women in the Medicaid and commercial insurance sample were classified into 3 distinct outcome groups: (1) those without any SMM during the delivery hospitalization and the postdelivery period (reference group), (2) those who exhibited at least 1 factor associated with SMM during the delivery hospitalization, and (3) those who exhibited any factor associated with de novo SMM after delivery discharge (defined as SMM that was first diagnosed in the inpatient setting during the 6 weeks [or 42 days] after discharge from the delivery hospitalization, conditional on no factor associated with SMM being identified during delivery). Data were analyzed from February to July 2020. Exposures Timing of SMM diagnosis. Main Outcomes and Measures Women with SMM were identified using diagnosis and procedure codes from the International Classification of Diseases, Ninth Revision, Clinical Modification for the 21 factors associated with SMM that were developed by the Centers for Disease Control and Prevention. Results A total of 2 667 325 women in the US with delivery hospitalizations between 2010 and 2014 were identified; of those, 809 377 women (30.3%) had Medicaid insurance (30.3%; mean [SD] age, 25.6 [5.5] years; 51.1% White), and 1 857 948 women (69.7%; mean [SD] age, 30.6 [5.4] years; 36.4% from the southern region of the US) had commercial insurance. Among those with Medicaid insurance, 17 584 women (2.2%) experienced SMM during the delivery hospitalization, and 3265 women (0.4%) experienced de novo SMM after delivery discharge. Among those with commercial insurance, 32 079 women (1.7%) experienced SMM during the delivery hospitalization, and 5275 women (0.3%) experienced de novo SMM after hospital discharge. A total of 5275 SMM cases (14.1%) and 3265 SMM cases (15.7%) among women with commercial and Medicaid insurance, respectively, developed de novo within 6 weeks after hospital discharge; of those, 3993 cases (75.7%) in the commercial insurance cohort and 2399 cases (73.5%) in the Medicaid cohort were identified in the first 2 weeks after discharge. The most common factors associated with SMM varied based on the timing of diagnosis. In the Medicaid population, non-Hispanic Black women (adjusted odds ratio [aOR], 1.53; 95% CI, 1.48-1.58), Hispanic women (aOR, 1.46; 95% CI, 1.37-1.57), and women of other races or ethnicities (aOR, 1.40; 95% CI, 1.33-1.47) had higher rates of SMM during delivery hospitalization than non-Hispanic White women; however, only the disparity between Black and White women (aOR, 1.69; 95% CI, 1.57-1.81) persisted into the postdischarge period. Conclusions and Relevance In this study, 14.1% of SMM cases in the Medicaid cohort and 15.7% of SMM cases in the commercial insurance cohort first occurred after the delivery hospitalization, with notable disparities in factors and maternal characteristics associated with the development of SMM. These findings suggest a need to expand the focus of SMM assessment to the postdelivery discharge period., This cohort study assesses the incidence, timing, factors, and maternal characteristics associated with de novo severe maternal morbidity after delivery discharge among women in the US.
- Published
- 2021
34. Association Between State Policies on Improving Opioid Prescribing in 2 States and Opioid Overdose Rates Among Reproductive-aged Women
- Author
-
Wanda D. Barfield, Shanna Cox, Rui Li, Gery P. Guy, Jean Y. Ko, Sarah C. Haight, Xu Ji, and Kun Zhang
- Subjects
Adult ,medicine.medical_specialty ,New York ,Kentucky ,Inappropriate Prescribing ,Drug Prescriptions ,Heroin ,03 medical and health sciences ,0302 clinical medicine ,Medicine ,Humans ,030212 general & internal medicine ,Medical prescription ,Opioid Epidemic ,business.industry ,030503 health policy & services ,Public health ,Health Policy ,Public Health, Environmental and Occupational Health ,Opioid overdose ,Opioid use disorder ,Interrupted Time Series Analysis ,Emergency department ,medicine.disease ,Analgesics, Opioid ,Opiate Overdose ,Pain Clinics ,Opioid ,Family medicine ,Prescription Drug Monitoring Programs ,Female ,0305 other medical science ,business ,medicine.drug ,State Government - Abstract
BACKGROUND The opioid overdose epidemic has been declared a public health emergency. Women are more likely than men to be prescribed opioid medications. Some states have adopted policies to improve opioid prescribing, including prescription drug monitoring programs (PDMPs) and pain clinic laws. OBJECTIVE Among reproductive-aged women, we examined the association of mandatory use laws for PDMPs in Kentucky (concurrent with a pain clinic law) and New York with overdose involving prescription opioids or heroin and opioid use disorder (OUD). STUDY DESIGN, SUBJECTS, AND OUTCOME MEASURES We conducted interrupted time series analyses estimating outcome changes after policy implementation in Kentucky and New York, compared with geographically close states without these policies (comparison states), using 2010-2014 State Inpatient and State Emergency Department Databases. Outcomes included rates of inpatient discharges and emergency department visits for overdoses involving prescription opioids or heroin and OUD among reproductive-aged women. RESULTS Relative to comparison states, following Kentucky's policy change, we found an immediate postpolicy decrease and a decreasing trend in the rate of overdoses involving prescription opioids, an immediate postpolicy increase in the rate of overdoses involving heroin, and a decreasing trend in the OUD rate (P
- Published
- 2020
35. Neonatal Opioid Withdrawal Syndrome
- Author
-
Stephen W, Patrick, Wanda D, Barfield, Brenda B, Poindexter, and Leslie, Walker-Harding
- Subjects
medicine.medical_specialty ,media_common.quotation_subject ,MEDLINE ,Affect (psychology) ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,030225 pediatrics ,Intervention (counseling) ,medicine ,Humans ,Mass Screening ,Psychiatry ,Mass screening ,media_common ,business.industry ,Infant, Newborn ,Opioid use disorder ,Opioid-Related Disorders ,medicine.disease ,United States ,Pregnancy Complications ,Opioid ,Practice Guidelines as Topic ,Pediatrics, Perinatology and Child Health ,Female ,business ,Neonatal Abstinence Syndrome ,Welfare ,medicine.drug - Abstract
The opioid crisis has grown to affect pregnant women and infants across the United States, as evidenced by rising rates of opioid use disorder among pregnant women and neonatal opioid withdrawal syndrome among infants. Across the country, pregnant women lack access to evidence-based therapies, including medications for opioid use disorder, and infants with opioid exposure frequently receive variable care. In addition, public systems, such as child welfare and early intervention, are increasingly stretched by increasing numbers of children affected by the crisis. Systematic, enduring, coordinated, and holistic approaches are needed to improve care for the mother-infant dyad. In this statement, we provide an overview of the effect of the opioid crisis on the mother-infant dyad and provide recommendations for management of the infant with opioid exposure, including clinical presentation, assessment, treatment, and discharge.
- Published
- 2020
36. Medical expenditures for hypertensive disorders during pregnancy that resulted in a live birth among privately insured women
- Author
-
Scott D. Grosse, Rui Li, Sundar S. Shrestha, Elena V. Kuklina, Jing Fang, Wanda D. Barfield, Guijing Wang, Shanna Cox, Jessica Leung, and Elizabeth C. Ailes
- Subjects
Gestational hypertension ,Adult ,medicine.medical_specialty ,Adolescent ,Databases, Factual ,Psychological intervention ,030204 cardiovascular system & hematology ,Severity of Illness Index ,Preeclampsia ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Service utilization ,Pregnancy ,Internal Medicine ,Medicine ,Humans ,Retrospective Studies ,030219 obstetrics & reproductive medicine ,Eclampsia ,business.industry ,Obstetrics ,Obstetrics and Gynecology ,Fee-for-Service Plans ,Hypertension, Pregnancy-Induced ,medicine.disease ,United States ,Female ,Diagnosis code ,Health Expenditures ,Preferred Provider Organizations ,business ,Live birth - Abstract
To estimate the excess maternal health services utilization and direct maternal medical expenditures associated with hypertensive disorders during pregnancy and one year postpartum among women with private insurance in the United States.We used 2008-2014 IBM MarketScan® Commercial Databases to identify women aged 15-44 who had a pregnancy resulting in live birth during 1/1/09-12/31/13 and were continuously enrolled with non-capitated or partially capitated coverage from 12 months before pregnancy through 12 months after delivery. Hypertensive disorders identified by diagnosis codes were categorized into three mutually exclusive types: preeclampsia and eclampsia, chronic hypertension, and gestational hypertension. Multivariate negative binomial and generalized linear models were used to estimate service utilization and expenditures, respectively.Per person excess health services utilization and medical expenditures during pregnancy and one year postpartum associated with hypertensive disorders (in 2014 US dollars).Women with preeclampsia and eclampsia, chronic hypertension, and gestational hypertension had $9,389, $6,041, and $2,237 higher mean medical expenditures compared to women without hypertensive disorders ($20,252), respectively (ps 0.001). One-third (36%) of excess expenditure associated with hypertensive disorders during pregnancy was attributable to outpatient services.Hypertensive disorders during pregnancy were associated with significantly higher health services utilization and medical expenditures among privately insured women with hypertensive disorders. Medical expenditures varied by types of hypertensive disorders. Stakeholders can use this information to assess the potential economic benefits of interventions that prevent these conditions or their complications.
- Published
- 2020
37. Women's Awareness and Healthcare Provider Discussions about Zika Virus during Pregnancy, United States, 2016-2017
- Author
-
Letitia Williams, Shanna Cox, Carrie K. Shapiro-Mendoza, Sascha R. Ellington, Philip A. Hastings, Ada C. Dieke, Martha Kapaya, Denise V. D’Angelo, Wanda D. Barfield, Holly B. Shulman, Leslie J.S. Harrison, Brenda L. Bauman, and Lee Warner
- Subjects
Microbiology (medical) ,medicine.medical_specialty ,Epidemiology ,Health Personnel ,030231 tropical medicine ,PRAMS ,lcsh:Medicine ,Prenatal care ,healthcare provider ,lcsh:Infectious and parasitic diseases ,Zika virus ,travel advisory ,03 medical and health sciences ,health care provider ,0302 clinical medicine ,Pregnancy ,medicine ,Humans ,lcsh:RC109-216 ,viruses ,030212 general & internal medicine ,Pregnancy Complications, Infectious ,ZIKV ,Travel ,biology ,business.industry ,Zika Virus Infection ,lcsh:R ,Dispatch ,Women’s Awareness and Healthcare Provider Discussions about Zika Virus during Pregnancy, United States, 2016–2017 ,Outbreak ,Zika Virus ,biology.organism_classification ,medicine.disease ,United States ,Infectious Diseases ,Family medicine ,Female ,prenatal care ,Live birth ,business ,Healthcare providers - Abstract
We surveyed women with a recent live birth who resided in 16 US states and 1 city during the 2016 Zika outbreak. We found high awareness about the risk of Zika virus infection during pregnancy and about advisories to avoid travel to affected areas but moderate levels of discussions with healthcare providers.
- Published
- 2020
38. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community
- Author
-
Sanaa Akbarali, Christine N. Mackie, Charlan D. Kroelinger, Wanda D. Barfield, S. Nicole Fehrenbach, Trish Mueller, Shanna Cox, Marion E. Rice, Hadley R. Hickner, Donna Addison, Alisa Velonis, Jean Y. Ko, Keriann Uesugi, Mary Kate Weber, Ellen Pliska, Natalie Foster, Mirelys Rodriguez, Lisa Romero, and Meghan T. Frey
- Subjects
business.industry ,Best practice ,Learning community ,Health Policy ,Stakeholder ,Infant, Newborn ,Stigma (botany) ,Collaborative learning ,Opioid use disorder ,General Medicine ,medicine.disease ,Opioid-Related Disorders ,United States ,Interdisciplinary Placement ,Nursing ,Pregnancy ,Action plan ,Virtual learning environment ,Medicine ,Humans ,Female ,Centers for Disease Control and Prevention, U.S ,business ,Health Education ,Neonatal Abstinence Syndrome - Abstract
The opioid crisis has impacted vulnerable populations, specifically pregnant and postpartum women, and infants prenatally exposed to substances, including infants with Neonatal Abstinence Syndrome. Lack of access to clinical and social services; potential stigma or discrimination; and lack of resources for provision of services, including screening and treatment, have impacted the health of these populations. In 2018, using a systems change approach, the Association of State and Territorial Health Officials (ASTHO) and the Centers for Disease Control and Prevention (CDC) convened an Opioid use disorder, Maternal outcomes, Neonatal abstinence syndrome Initiative Learning Community (OMNI LC) that included other federal agencies, national clinical and nonclinical organizations, and 12 state leadership groups. The purpose of the OMNI LC was to determine areas of focus and identify strategies and best practices for implementing systems change to improve maternal and infant outcomes associated with opioid use disorder (OUD) during the perinatal period. Activities included in-person convenings with policy goal action plan development, virtual learning sessions, intensive technical assistance (TA), and temporary field placements. The OMNI LC partnering agencies and state teams met bimonthly for the first year of the initiative. At the in-person convening, state teams identified barriers to developing and implementing systems change in activity-specific action plans within five areas of focus: financing and coverage; access to and coordination of quality services; provider training and awareness; ethical, legal, and social considerations; and data, monitoring, and evaluation. State teams also identified stakeholder partnerships as a necessary component of strategy development in all areas of focus. Four virtual learning sessions were conducted on the areas of focus identified by state teams, and ASTHO conducted three intensive TA opportunities, and five states were identified for temporary field placement. To successfully address the impact of the opioid crisis on pregnant and postpartum women and infants, states developed innovative strategies focused on increasing support, services, and resources. Moving forward, state teams will participate in two additional in-person meetings, continue to identify barriers to the work, refine and customize action plans, and set new goals, to effect broad-ranging systems change for these vulnerable populations.
- Published
- 2020
39. Paternal Involvement and Maternal Perinatal Behaviors: Pregnancy Risk Assessment Monitoring System, 2012-2015
- Author
-
Martha Kapaya, Wanda D. Barfield, Craig F. Garfield, Sheree L. Boulet, Ruben A. Smith, Leslie Harrison, Clarissa D. Simon, Karen Pazol, Lee Warner, and Katherine Kortsmit
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pregnancy risk ,Adolescent ,Alcohol Drinking ,Mothers ,Paternity ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,030225 pediatrics ,Infant morbidity ,medicine ,Humans ,Maternal Behavior ,030505 public health ,Marital Status ,Obstetrics ,business.industry ,Research ,Smoking ,Public Health, Environmental and Occupational Health ,Monitoring system ,Prenatal Care ,United States ,Breast Feeding ,Birth Certificates ,Female ,0305 other medical science ,business - Abstract
Objectives: Paternal involvement is associated with improved infant and maternal outcomes. We compared maternal behaviors associated with infant morbidity and mortality among married women, unmarried women with an acknowledgment of paternity (AOP; a proxy for paternal involvement) signed in the hospital, and unmarried women without an AOP in a representative sample of mothers in the United States from 32 sites. Methods: We analyzed 2012-2015 data from the Pregnancy Risk Assessment Monitoring System, which collects site-specific, population-based data on preconception, prenatal and postpartum behaviors, and experiences from women with a recent live birth. We calculated adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs) to examine associations between level of paternal involvement and maternal perinatal behaviors. Results: Of 113 020 respondents (weighted N = 6 159 027), 61.5% were married, 27.4% were unmarried with an AOP, and 11.1% were unmarried without an AOP. Compared with married women and unmarried women with an AOP, unmarried women without an AOP were less likely to initiate prenatal care during the first trimester (married, aPR [95% CI], 0.94 [0.92-0.95]; unmarried with AOP, 0.97 [0.95-0.98]), ever breastfeed (married, 0.89 [0.87-0.90]; unmarried with AOP, 0.95 [0.94-0.97]), and breastfeed at least 8 weeks (married, 0.76 [0.74-0.79]; unmarried with AOP, 0.93 [0.90-0.96]) and were more likely to use alcohol during pregnancy (married, 1.20 [1.05-1.37]; unmarried with AOP, 1.21 [1.06-1.39]) and smoke during pregnancy (married, 3.18 [2.90-3.49]; unmarried with AOP, 1.23 [1.15-1.32]) and after pregnancy (married, 2.93 [2.72-3.15]; unmarried with AOP, 1.17 [1.10-1.23]). Conclusions: Use of information on the AOP in addition to marital status provides a better understanding of factors that affect maternal behaviors.
- Published
- 2020
40. Assisted Reproductive Technology Surveillance — United States, 2015
- Author
-
Saswati Sunderam, Sheree L. Boulet, Suzanne G. Folger, Wanda D. Barfield, Sara Crawford, Dmitry M. Kissin, and Lee Warner
- Subjects
Adult ,medicine.medical_specialty ,Health (social science) ,Adolescent ,Reproductive Techniques, Assisted ,Epidemiology ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,medicine.medical_treatment ,Population ,Fertility ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Pregnancy ,medicine ,Humans ,030212 general & internal medicine ,education ,media_common ,Surveillance Summaries ,education.field_of_study ,030219 obstetrics & reproductive medicine ,Assisted reproductive technology ,business.industry ,Public health ,Infant, Newborn ,Pregnancy Outcome ,Gestational age ,Infant, Low Birth Weight ,medicine.disease ,United States ,Low birth weight ,Premature birth ,Population Surveillance ,Premature Birth ,Female ,Pregnancy, Multiple ,medicine.symptom ,business ,Infant, Premature ,Demography - Abstract
Problem/Condition Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Although the majority of infants conceived through ART are singletons, women who undergo ART procedures are more likely than women who conceive naturally to deliver multiple-birth infants. Multiple births pose substantial risks for both mothers and infants, including obstetric complications, preterm delivery (37 years). Among women aged
- Published
- 2018
41. Vital Signs: Trends and Disparities in Infant Safe Sleep Practices — United States, 2009–2015
- Author
-
Wanda D. Barfield, Sharyn E. Parks, Deborah L. Dee, Lee Warner, Carrie K. Shapiro-Mendoza, Katherine Kortsmit, Kim Burley, Jennifer M. Bombard, Denise V. D’Angelo, Leslie J.S. Harrison, Carri Cottengim, Christine K. Olson, Brian Morrow, Holly B. Shulman, Ruben A. Smith, Shanna Cox, and Charlan D. Kroelinger
- Subjects
Adult ,medicine.medical_specialty ,Health (social science) ,Epidemiology ,Health, Toxicology and Mutagenesis ,Vital signs ,Mothers ,Poison control ,Occupational safety and health ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,030225 pediatrics ,Injury prevention ,medicine ,Humans ,030212 general & internal medicine ,Vital Signs ,business.industry ,Infant Care ,Infant ,Health Status Disparities ,General Medicine ,Sudden infant death syndrome ,United States ,Infant mortality ,Socioeconomic Factors ,Accidental ,Emergency medicine ,Female ,Sleep ,business ,Sudden Infant Death - Abstract
There have been dramatic improvements in reducing infant sleep-related deaths since the 1990s, when recommendations were introduced to place infants on their backs for sleep. However, there are still approximately 3,500 sleep-related deaths among infants each year in the United States, including those from sudden infant death syndrome, accidental suffocation and strangulation in bed, and unknown causes. Unsafe sleep practices, including placing infants in a nonsupine (on side or on stomach) sleep position, bed sharing, and using soft bedding in the sleep environment (e.g., blankets, pillows, and soft objects) are modifiable risk factors for sleep-related infant deaths.
- Published
- 2018
42. Geographic Access to Critical Care Obstetrics for Women of Reproductive Age by Race and Ethnicity
- Author
-
Ekwutosi M. Okoroh, Taleria R. Fuller, Shanna Cox, Charlan D. Kroelinger, Michael Monsour, Wanda D. Barfield, and Mary D. Brantley
- Subjects
Adult ,medicine.medical_specialty ,Adolescent ,Critical Care ,Referral ,Ethnic group ,Health Services Accessibility ,Article ,American Community Survey ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Pregnancy ,medicine ,Humans ,030212 general & internal medicine ,Obstetrics and Gynecology Department, Hospital ,Human services ,Spatial Analysis ,030219 obstetrics & reproductive medicine ,Geography ,Obstetrics ,business.industry ,Racial Groups ,Obstetrics and Gynecology ,Census ,Health equity ,United States ,Pacific islanders ,Female ,Residence ,Rural area ,business - Abstract
Background The goal of risk-appropriate maternal care is for high-risk pregnant women to receive specialized obstetrical services in facilities equipped with capabilities and staffing to provide care or transfer to facilities with resources available to provide care. In the United States, geographic access to critical care obstetrics varies. It is unknown whether this variation in proximity to critical care obstetrics differs by race, ethnicity, and region. Objective We examined the geographic access, defined as residence within 50 miles of a facility capable of providing risk-appropriate critical care obstetrics services for women of reproductive age, by distribution of race and ethnicity. Study Design Descriptive spatial analysis was used to assess geographic distance to critical care obstetrics for women of reproductive age by race and ethnicity. Data were analyzed geographically: nationally, by the Department of Health and Human Services regions, and by all 50 states and the District of Columbia. Dot density analysis was used to visualize geographic distributions of women by residence and critical care obstetrics facilities across the United States. Proximity analysis defined the proportion of women living within an approximate 50-mile radius of facilities. Source data included the 2015 American Community Survey from the United States Census Bureau and the 2015 American Hospital Association Annual Survey. Results Geographic access to critical care obstetrics was the greatest for Asian and Pacific Islander women of reproductive age (95.8%), followed by black (93.5%), Hispanic (91.4%), and white women of reproductive age (89.1%). American Indian and Alaska Native women had more limited geographic access (66%) in all regions. Visualization of proximity to critical care obstetrics indicated that facilities were predominantly located in urban areas, which may limit access to women in frontier or rural areas of states including nationally recognized reservations where larger proportions of white women and American Indian and Alaska Native women reside, respectively. Conclusion Disparities in proximity to critical care obstetrics exist in rural and frontier areas of the United States, which affect white women and American Indian and Alaska Native women, primarily. Examining insurance coverage, interstate hospital referral networks, and transportation barriers may provide further insight into critical care obstetrics accessibility. Further exploring the role of other equity-based measures of access on disparities beyond geography is warranted.
- Published
- 2021
43. Meeting Summary: State and Local Implementation Strategies for Increasing Access to Contraception During Zika Preparedness and Response — United States, September 2016
- Author
-
Dana Meaney-Delman, Meghan T. Frey, Karen Pazol, Lee Warner, Lisa Romero, Isabel Morgan, Kathryn M. Curtis, Eva Lathrop, Shanna Cox, Charlan D. Kroelinger, Wanda D. Barfield, and Denise J. Jamieson
- Subjects
Pregnancy ,Microcephaly ,030219 obstetrics & reproductive medicine ,Health (social science) ,biology ,Epidemiology ,business.industry ,Transmission (medicine) ,Health, Toxicology and Mutagenesis ,Context (language use) ,General Medicine ,medicine.disease ,biology.organism_classification ,Zika virus ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Local government ,Preparedness ,Interim ,Environmental health ,medicine ,Full Report ,030212 general & internal medicine ,business - Abstract
Zika virus infection during pregnancy is a cause of microcephaly and other serious brain abnormalities (1). To support state and territory response to the threat of Zika, CDC's Interim Zika Response Plan outlined activities for vector control; clinical management of exposed pregnant women and infants; targeted communication about Zika virus transmission among women and men of reproductive age; and primary prevention of Zika-related adverse pregnancy and birth outcomes by prevention of unintended pregnancies through increased access to contraception.* The most highly effective,† reversible contraception includes intrauterine devices and implants, known as long-acting reversible contraception (LARC). On September 28, 2016, the Association of Maternal and Child Health Programs (AMCHP) and CDC facilitated a meeting in Atlanta, Georgia, of representatives from 15 states to identify state-led efforts to implement seven CDC-published strategies aimed at increasing access to contraception in the context of Zika virus (2). Qualitative data were collected from participating jurisdictions. The number of states reporting implementation of each strategy ranged from four to 11. Participants identified numerous challenges, particularly for strategies implemented less frequently. Examples of barriers were discussed and presented with corresponding approaches to address each barrier. Addressing these barriers could facilitate increased access to contraception, which might decrease the number of unintended pregnancies affected by Zika virus.
- Published
- 2017
44. Persistent Racial/Ethnic Disparities in Supine Sleep Positioning among US Preterm Infants, 2000-2015
- Author
-
Suhong Tong, Sunah S. Hwang, Susan Niermeyer, Wanda D. Barfield, Beth M. McManus, Catherine Battaglia, Laura Pyle, Ruben A. Smith, and Angela Sauaia
- Subjects
Adult ,medicine.medical_specialty ,Supine position ,Racial disparity ,Population ,Ethnic group ,Mothers ,Gestational Age ,03 medical and health sciences ,0302 clinical medicine ,030225 pediatrics ,Supine Position ,Late preterm ,Humans ,Medicine ,030212 general & internal medicine ,education ,education.field_of_study ,Marital Status ,business.industry ,Obstetrics ,Racial Groups ,Significant difference ,Infant, Newborn ,Monitoring system ,United States ,Racial ethnic ,Population Surveillance ,Pediatrics, Perinatology and Child Health ,Educational Status ,Female ,Sleep ,business ,Infant, Premature ,Maternal Age - Abstract
To assess trends in racial disparity in supine sleep positioning (SSP) across racial/ethnic groups of infants born early preterm (Early preterm;34 weeks) and late preterm (Late preterm; 34-36 weeks) from 2000 to 2015.We analyzed Pregnancy Risk Assessment Monitoring System data (a population-based perinatal surveillance system) from 16 US states from 2000 to 2015 (Weighted N = 1 020 986). Marginal prevalence of SSP by year was estimated for infants who were early preterm and late preterm, adjusting for maternal and infant characteristics. After stratifying infants who were early preterm and late preterm, we compared the aOR of SSP trends across racial/ethnic groups by testing the time-race interaction.From 2000 to 2015, Non-Hispanic Black infants had lower odds of SSP compared with Non-Hispanic White infants for early preterm (aOR 0.61; 95% CI 0.47-0.78) and late preterm (aOR 0.44; 95% CI 0.34-0.56) groups. For Hispanic infants, there was no statistically significant difference for either preterm group when compared with Non-Hispanic White infants. aOR of SSP increased (on average) annually by 10.0%, 7.3%, and 7.7%, respectively, in Non-Hispanic White, Non-Hispanic Black, and Hispanic early preterm infants and by 5.8%, 5.9%, and 4.8% among Non-Hispanic White, Non-Hispanic Black, and Hispanic late preterm infants. However, there were no significant between-group differences in annual changes (Early preterm: P = .11; Late preterm: P = .25).SSP increased for all racial/ethnic preterm groups from 2000 to 2015. However, the racial/ethnic disparity in SSP among early preterm and late preterm groups persists.
- Published
- 2021
45. Association of Preterm Birth Rate With COVID-19 Statewide Stay-at-Home Orders in Tennessee
- Author
-
Carrie K. Shapiro-Mendoza, William D. Dupont, Elizabeth Harvey, Stephen W. Patrick, Wanda D. Barfield, Morgan F. McDonald, and Elizabeth McNeer
- Subjects
Pregnancy ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Recem nascido ,medicine.disease ,Infant newborn ,Birth rate ,Premature birth ,Pediatrics, Perinatology and Child Health ,medicine ,business ,Demography - Published
- 2021
46. Measures Taken to Prevent Zika Virus Infection During Pregnancy — Puerto Rico, 2016
- Author
-
Karen Pazol, Carrie K. Shapiro-Mendoza, Brenda Rivera, Carmen Deseda, Shanna Cox, Tanya Williams, Holly B. Shulman, Leslianne Soto, Sascha R. Ellington, Ruben A. Smith, Aspy J. Taraporewalla, Lisa Romero, Margaret A. Honein, Beatriz Salvesen von Essen, Wanda D. Barfield, Denise J. Jamieson, Lee Warner, Denise V. D’Angelo, Aurea Rodriguez, Mark J. Lamias, Wanda I. Hernandez-Virella, Manuel I. Vargas, Deborah L. Dee, Marion E. Rice, Eva Lathrop, and Leslie Harrison
- Subjects
Adult ,medicine.medical_specialty ,Health (social science) ,Mosquito Control ,Epidemiology ,Health, Toxicology and Mutagenesis ,Risk Assessment ,Zika virus ,Condoms ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Health Information Management ,Protective Clothing ,Pregnancy ,030225 pediatrics ,Medicine ,Infection control ,Humans ,Mass Screening ,030212 general & internal medicine ,Full Report ,Pregnancy Complications, Infectious ,Mass screening ,Sexual Abstinence ,biology ,business.industry ,Obstetrics ,Zika Virus Infection ,Public health ,Puerto Rico ,General Medicine ,biology.organism_classification ,medicine.disease ,Mosquito control ,Sexual abstinence ,Insect Repellents ,Public Health Practice ,Female ,Pregnant Women ,business ,Live birth - Abstract
Zika virus infection during pregnancy remains a serious health threat in Puerto Rico. Infection during pregnancy can cause microcephaly, brain abnormalities, and other severe birth defects (1). From January 1, 2016 through March 29, 2017, Puerto Rico reported approximately 3,300 pregnant women with laboratory evidence of possible Zika virus infection (2). There is currently no vaccine or intervention to prevent the adverse effects of Zika virus infection during pregnancy; therefore, prevention has been the focus of public health activities, especially for pregnant women (3). CDC and the Puerto Rico Department of Health analyzed data from the Pregnancy Risk Assessment Monitoring System Zika Postpartum Emergency Response (PRAMS-ZPER) survey conducted from August through December 2016 among Puerto Rico residents with a live birth. Most women (98.1%) reported using at least one measure to avoid mosquitos in their home environment. However, only 45.8% of women reported wearing mosquito repellent daily, and 11.5% reported wearing pants and shirts with long sleeves daily. Approximately one third (38.5%) reported abstaining from sex or using condoms consistently throughout pregnancy. Overall, 76.9% of women reported having been tested for Zika virus by their health care provider during the first or second trimester of pregnancy. These results can be used to assess and refine Zika virus infection prevention messaging and interventions for pregnant women and to reinforce measures to promote prenatal testing for Zika.
- Published
- 2017
47. Trends in Repeat Births and Use of Postpartum Contraception Among Teens — United States, 2004–2015
- Author
-
Leslie J.S. Harrison, Charlan D. Kroelinger, Katherine Bower, Ruben A. Smith, Wanda D. Barfield, Martha Kapaya, Deborah L. Dee, Shanna Cox, Denise V. D’Angelo, Lee Warner, Ayanna Harrison, Karen Pazol, Amy M. Fasula, Emilia H. Koumans, and Nikki Mayes
- Subjects
Pediatrics ,medicine.medical_specialty ,Health (social science) ,Epidemiology ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,education ,Population ,Fertility ,Prenatal care ,Birth rate ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Medicine ,030212 general & internal medicine ,media_common ,education.field_of_study ,030219 obstetrics & reproductive medicine ,business.industry ,General Medicine ,Family planning ,business ,Live birth ,human activities ,Developed country ,Postpartum period ,Demography - Abstract
Teen* childbearing (one or more live births before age 20 years) can have negative health, social, and economic consequences for mothers and their children (1). Repeat teen births (two or more live births before age 20 years) can constrain the mother's ability to take advantage of educational and workforce opportunities (2), and are more likely to be preterm or of low birthweight than first teen births (3). Despite the historic decline in the U.S. teen birth rate during 1991-2015, from 61.8 to 22.3 births per 1,000 females aged 15-19 years (4), many teens continue to have repeat births (3). The American College of Obstetricians and Gynecologists and the American Academy of Pediatrics both recommend that clinicians counsel women (including teens) during prenatal care about birth spacing and postpartum contraceptive use (5), including the safety and effectiveness of long-acting reversible methods that can be initiated immediately postpartum. To expand upon prior research assessing patterns and trends in repeat childbearing and postpartum contraceptive use among teens with a recent live birth (i.e., 2-6 months after delivery) (3), CDC analyzed data from the National Vital Statistics System natality files (2004 and 2015) and the Pregnancy Risk Assessment Monitoring System (PRAMS; 2004-2013). The number and proportion of teen births that were repeat births decreased from 2004 (82,997; 20.1%) to 2015 (38,324; 16.7%); in 2015, the percentage of teen births that were repeat births varied by state from 10.6% to 21.4%. Among sexually active teens with a recent live birth, postpartum use of the most effective contraceptive methods (intrauterine devices and contraceptive implants) increased from 5.3% in 2004 to 25.3% in 2013; however, in 2013, approximately one in three reported using either a least effective method (15.7%) or no method (17.2%). Strategies that comprehensively address the social and health care needs of teen parents can facilitate access to and use of effective methods of contraception and help prevent repeat teen births.
- Published
- 2017
48. CDC Grand Rounds: Public Health Strategies to Prevent Neonatal Abstinence Syndrome
- Author
-
Cheryl S. Broussard, Sara Beth Wolicki, Jean Y. Ko, John K. Iskander, Kimberly A. Yonkers, Stephen W. Patrick, Wanda D. Barfield, and Rebecca Naimon
- Subjects
Health Knowledge, Attitudes, Practice ,medicine.medical_specialty ,Pediatrics ,Health (social science) ,Epidemiology ,Health, Toxicology and Mutagenesis ,Legislation as Topic ,Irritability ,Heroin ,03 medical and health sciences ,0302 clinical medicine ,Cost of Illness ,Health Information Management ,Pregnancy ,030225 pediatrics ,medicine ,Humans ,030212 general & internal medicine ,Medical prescription ,Intensive care medicine ,business.industry ,Grand Rounds ,Public health ,Infant, Newborn ,Opioid-Related Disorders ,Opioid use disorder ,General Medicine ,medicine.disease ,United States ,3. Good health ,Opioid ,Prenatal Exposure Delayed Effects ,Public Health Practice ,Female ,Centers for Disease Control and Prevention, U.S ,medicine.symptom ,business ,Neonatal Abstinence Syndrome ,medicine.drug - Abstract
Neonatal abstinence syndrome (NAS) is a drug withdrawal syndrome that most commonly occurs in infants after in utero exposure to opioids, although other substances have also been associated with the syndrome (1). NAS usually appears within 48-72 hours of birth with a constellation of clinical signs, including central nervous system irritability (e.g., tremors), gastrointestinal dysfunction (e.g., feeding difficulties), and temperature instability (1) (Box 1). Opioid exposure during pregnancy might result from clinician-approved use of prescription opioids for pain relief; misuse or abuse of prescription opioids; illicit use (e.g., heroin); or medication-assisted treatment (MAT) of opioid use disorder (2) (Box 2).
- Published
- 2017
49. Why We Need Evidence-Based, Community-Wide Approaches for Prevention of Teen Pregnancy
- Author
-
Wanda D. Barfield, Evelyn M. Kappeler, and Lee Warner
- Subjects
Sexual behavior ,Economic growth ,Evidence-based practice ,Adolescent ,education ,Ethnic group ,Sex Education ,Article ,Unintended pregnancy ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,030225 pediatrics ,Political science ,Ethnicity ,medicine ,Humans ,Pediatrics, Perinatology, and Child Health ,Community Health Services ,030212 general & internal medicine ,Primary prevention ,Evidence-Based Medicine ,Adolescent pregnancy ,Teen pregnancy prevention ,Public Health, Environmental and Occupational Health ,Gender studies ,Evidence-based medicine ,medicine.disease ,United States ,Psychiatry and Mental health ,General partnership ,Pregnancy in Adolescence ,Pediatrics, Perinatology and Child Health ,behavior and behavior mechanisms ,Female ,human activities ,Teen pregnancy - Abstract
Teen pregnancy and childbearing have declined over the past two decades to historic lows. The most recent declines have occurred during a time of coordinated national efforts focused on teen pregnancy. This article highlights a federal partnership to reduce teen pregnancy through the implementation of innovative, evidence-based approaches in affected communities, with a focus on reaching African-American and Latino/Hispanic youth. This initiative has the potential to transform the design and implementation of future teen pregnancy prevention efforts and provide a model that can be replicated in communities across the nation.
- Published
- 2017
50. Assisted Reproductive Technology Surveillance — United States, 2014
- Author
-
Sara Crawford, Dmitry M. Kissin, Saswati Sunderam, Wanda D. Barfield, Lee Warner, Denise J. Jamieson, and Suzanne G. Folger
- Subjects
Adult ,medicine.medical_specialty ,Health (social science) ,Adolescent ,Reproductive Techniques, Assisted ,Epidemiology ,Health, Toxicology and Mutagenesis ,media_common.quotation_subject ,medicine.medical_treatment ,Fertility ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Health Information Management ,Pregnancy ,Humans ,Medicine ,030212 general & internal medicine ,Young adult ,media_common ,Surveillance Summaries ,030219 obstetrics & reproductive medicine ,Assisted reproductive technology ,In vitro fertilisation ,business.industry ,Obstetrics ,Infant, Newborn ,Pregnancy Outcome ,Infant, Low Birth Weight ,medicine.disease ,United States ,Fertility clinic ,Low birth weight ,Premature birth ,Population Surveillance ,Premature Birth ,Female ,Pregnancy, Multiple ,medicine.symptom ,business ,Infant, Premature - Abstract
Problem/Condition Since the first U.S. infant conceived with assisted reproductive technology (ART) was born in 1981, both the use of ART and the number of fertility clinics providing ART services have increased steadily in the United States. ART includes fertility treatments in which eggs or embryos are handled in the laboratory (i.e., in vitro fertilization [IVF] and related procedures). Women who undergo ART procedures are more likely than women who conceive naturally to deliver multiple-birth infants. Multiple births pose substantial risks to both mothers and infants, including obstetric complications, preterm delivery, and low birthweight infants. This report provides state-specific information for the United States (including the District of Columbia and Puerto Rico) on ART procedures performed in 2014 and compares birth outcomes that occurred in 2014 (resulting from ART procedures performed in 2013 and 2014) with outcomes for all infants born in the United States in 2014. Period Covered 2014. Description of System In 1996, CDC began collecting data on ART procedures performed in fertility clinics in the United States as mandated by the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA) (Public Law 102–493). Data are collected through the National ART Surveillance System (NASS), a web-based data collection system developed by CDC. This report includes data from 52 reporting areas (the 50 states, the District of Columbia, and Puerto Rico). Results In 2014, a total of 169,568 ART procedures (range: 124 in Wyoming to 21,018 in California) with the intent to transfer at least one embryo were performed in 458 U.S. fertility clinics and reported to CDC. These procedures resulted in 56,028 live-birth deliveries (range: 52 in Wyoming to 7,230 in California) and 68,782 infants born (range: 64 in Wyoming to 8,793 in California). Nationally, the total number of ART procedures performed per million women of reproductive age (15–44 years), a proxy measure of the ART usage rate, was 2,647 (range: 364 in Puerto Rico to 6,726 in Massachusetts). ART use exceeded the national average in 13 reporting areas (Connecticut, Delaware, the District of Columbia, Hawaii, Illinois, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Virginia). Eight reporting areas (Connecticut, the District of Columbia, Hawaii, Illinois, Maryland, Massachusetts, New Jersey, and New York) had rates of ART use exceeding 1.5 times the national average. Nationally, among ART transfer procedures in patients using fresh embryos from their own eggs, the average number of embryos transferred increased with increasing age of the woman (1.7 among women aged 37 years). Among women aged
- Published
- 2017
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.